PortaCellTec biosciences GmbH

Organic Anion Transporters (OATs)

The physiological, pharmaceutical and pathological role of Organic Anion transporters (OATs) of the SLC22 Family

General overview
The human organic anion transporters (OATs) of the SLC22 gene family are polyspecific transporters, mainly located in kidneys. Selected OATs are expressed also in liver, placenta, and brain.
OATs interact with endogenous metabolic end products such as urate and acidic neurotransmitter metabolites, as well as with a multitude of widely used drugs, including antibiotics, antihypertensives, antivirals, anti-inflammatory drugs, diuretics and uricosurics. Thereby, OATs play an important role in renal and hepatic drug elimination and have an impact on pharmacokinetics.
Since OATs are typically found at boundary epithelia, these transporters play an important role in distribution and excretion of drugs and endogenous substrates like urate. Moreover, OATs can be the site of drug-drug interactions during competition of two or more drugs for the same transporter, and mediate cell damage by transporting cytotoxic compounds.


Driving
force and mechanism of drug transport by OATsSchema OAT
OATs do not directly utilize ATP hydrolysis for energizing substrate translocation. Most, if not all, members of the OAT family operate as anion exchangers, i.e., they couple the uptake of an organic anion (OA-) into the cell to the release of another organic anion from the cell.
In kidney proximal tubules, OATs are functionally coupled to Na+-driven mono and dicarboxylate (Dic2+) transporters that establish and maintain the intracellular > extracellular gradients of lactate, nicotinate, and α-ketoglutarate.

 

 

 

Example for biomedical impact
Several studies reported an increase in serum urate level during antihypertensive therapy with low-dose diuretics like torasemide and hydrochlorothiazide. These diuretics are substrates of the OATs and, by counter exchange, cause increased urate absorption, leading to hyperuricemia.

 

PortaCellTec

News

New validated products:

  • mNtcp
  • mOct1

Events

3rd German Pharm-Tox Summit
Göttingen, Germany
26 February - 1 March 2018


Pharmaforum
Saarbrücken, Germany
8 March 2018

 

AAPS Workshop
Virginia, USA
16 - 18 April 2018

 

20th Barrier- and
Transporter-Meeting

Bad Herrenalb, Germany
7 - 9 May 2018

Greifswalder Transporttage 2018
Greifswald, Germany
7 - 9 September 2018

 


Guidance for Industry (FDA and EMA)

Publications